Literature DB >> 31254112

Obstructive sleep apnea and hypertension in pediatric chronic kidney disease.

Anne Tsampalieros1, Henrietta Blinder2,3, Lynda Hoey4, Franco Momoli2,3,5, Nicholas Barrowman4,6, Janusz Feber1, Naomi Spitale7, Sherri Lynne Katz8,9.   

Abstract

BACKGROUND: Children with chronic kidney disease (CKD) are at risk for obstructive sleep apnea (OSA) and hypertension. The objectives of this study were to explore associations between OSA severity using the apnea-hypopnea-index(AHI) and obstructive apnea-hypopnea-index(OAHI) on polysomnography (PSG), OSA symptoms, and measures of hypertension in children with CKD.
METHODS: One-night in-laboratory PSGs and 24-h ambulatory blood pressure monitoring (ABPM) were performed on children with CKD stages 2-5 (non-dialysis dependent). Sleep questionnaires, including the modified Epworth Sleepiness Scale (ESS) and the Pediatric Sleep Questionnaire (PSQ), were administered during the sleep study.
RESULTS: Nineteen children and adolescents completed a PSG and questionnaires and thirteen completed ABPMs. Mean (standard deviation) age at the time of the sleep study was 14.1 (3.2) years. Eleven (58%) participants had CKD stage two, and eight (42%) had stage 3-4. None of the participants were found to have OSA on PSG. One participant had a positive ESS score (≥ 11) and five participants had positive PSQ scores (≥  eight). Night systolic and diastolic pressures were strongly correlated with the OAHI (r = 0.67 and r = 0.69, respectively, p < 0.05), while the AHI was not correlated with any blood pressure measures.
CONCLUSIONS: Our study did not find OSA on PSG in children with predominantly mild to moderate CKD. The OAHI was found to be strongly correlated with nighttime blood pressures. Future prospective studies with a larger sample size are needed to monitor for potential progression of symptoms and findings on PSG in pediatric patients as they evolve across the spectrum of CKD.

Entities:  

Keywords:  Children; Chronic kidney disease; Hypertension; Polysomnography; Sleep-disordered breathing

Year:  2019        PMID: 31254112     DOI: 10.1007/s00467-019-04295-7

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  45 in total

1.  The Childhood Adenotonsillectomy Trial (CHAT): rationale, design, and challenges of a randomized controlled trial evaluating a standard surgical procedure in a pediatric population.

Authors:  Susan Redline; Raouf Amin; Dean Beebe; Ronald D Chervin; Susan L Garetz; Bruno Giordani; Carole L Marcus; Renee H Moore; Carol L Rosen; Raanan Arens; David Gozal; Eliot S Katz; Ronald B Mitchell; Hiren Muzumdar; H G Taylor; Nina Thomas; Susan Ellenberg
Journal:  Sleep       Date:  2011-11-01       Impact factor: 5.849

2.  Ambulatory blood pressure monitoring in children and adolescents: recommendations for standard assessment: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the council on cardiovascular disease in the young and the council for high blood pressure research.

Authors:  Elaine Urbina; Bruce Alpert; Joseph Flynn; Laura Hayman; Gregory A Harshfield; Marc Jacobson; Larry Mahoney; Brian McCrindle; Michele Mietus-Snyder; Julia Steinberger; Stephen Daniels
Journal:  Hypertension       Date:  2008-08-04       Impact factor: 10.190

Review 3.  Cardiovascular disease in children with chronic kidney disease.

Authors:  Mark M Mitsnefes
Journal:  J Am Soc Nephrol       Date:  2012-03-01       Impact factor: 10.121

4.  Pediatric sleep questionnaire (PSQ): validity and reliability of scales for sleep-disordered breathing, snoring, sleepiness, and behavioral problems.

Authors: 
Journal:  Sleep Med       Date:  2000-02-01       Impact factor: 3.492

5.  Elevated blood pressure during sleep and wake in children with sleep-disordered breathing.

Authors:  Rosemary S C Horne; Joel S C Yang; Lisa M Walter; Heidi L Richardson; Denise M O'Driscoll; Alison M Foster; Shi Wong; Michelle L Ng; Farhat Bashir; Ruth Patterson; Gillian M Nixon; Damien Jolley; Adrian M Walker; Vicki Anderson; John Trinder; Margot J Davey
Journal:  Pediatrics       Date:  2011-06-27       Impact factor: 7.124

6.  Declining kidney function increases the prevalence of sleep apnea and nocturnal hypoxia.

Authors:  David D M Nicholl; Sofia B Ahmed; Andrea H S Loewen; Brenda R Hemmelgarn; Darlene Y Sola; Jaime M Beecroft; Tanvir C Turin; Patrick J Hanly
Journal:  Chest       Date:  2012-01-05       Impact factor: 9.410

7.  Sleep disturbances in children and adolescents with non-dialysis-dependent chronic kidney disease.

Authors:  Rajiv Sinha; Ira D Davis; Mina Matsuda-Abedini
Journal:  Arch Pediatr Adolesc Med       Date:  2009-09

8.  Sleep quality assessment using polysomnography in children on regular hemodialysis.

Authors:  Ahmed M El-Refaey; Riad M Elsayed; Amr Sarhan; Ashraf Bakr; Ayman Hammad; Atef Elmougy; Ahmed Y Aboelyazeed
Journal:  Saudi J Kidney Dis Transpl       Date:  2013-07

9.  Acute and chronic effects of sleep duration on blood pressure.

Authors:  Chun Ting Au; Crover Kwok Wah Ho; Yun Kwok Wing; Hugh Simon Lam; Albert Martin Li
Journal:  Pediatrics       Date:  2013-12-16       Impact factor: 7.124

10.  Ventricular dysfunction in children with obstructive sleep apnea: radionuclide assessment.

Authors:  A Tal; A Leiberman; G Margulis; S Sofer
Journal:  Pediatr Pulmonol       Date:  1988
View more
  3 in total

Review 1.  Prevalence of sleep disorders in children with chronic kidney disease: a meta-analysis.

Authors:  Kun-Tai Kang; Ming-Tzer Lin; Yin-Cheng Chen; Chia-Hsuan Lee; Wei-Chung Hsu; Ray-E Chang
Journal:  Pediatr Nephrol       Date:  2022-04-20       Impact factor: 3.651

2.  Gender-Specific Longitudinal Association of Sleep Duration with Blood Pressure among Children: Evidence from CHNS 2004-2015.

Authors:  Lili Huang; Jiajun Lyu; Zichong Long; Yuanqing Xia; Yiting Chen; Xiuxia Ye; Shenghui Li
Journal:  Int J Hypertens       Date:  2020-07-12       Impact factor: 2.420

Review 3.  Mechanisms of cognitive dysfunction in CKD.

Authors:  Davide Viggiano; Carsten A Wagner; Gianvito Martino; Maiken Nedergaard; Carmine Zoccali; Robert Unwin; Giovambattista Capasso
Journal:  Nat Rev Nephrol       Date:  2020-03-31       Impact factor: 28.314

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.